Company
Dermata Therapeutics, Inc.
DRMA · CIK 0001853816
Acquisition (code A) of 102,040 shares; price not stated (see filing).
Reporting Person Van Hoose Kyri K. · Officer Title SVP, CFO · Transaction Code A
Traded Aug 16, 2026 · Disclosed Aug 18, 2026
Source: SEC Form 4 · 0001493152-26-039046 · filed 2026-08-18 · View filing →
Acquisition (code A) of 170,068 shares; price not stated (see filing).
Reporting Person PROEHL GERALD T · Officer Title PRESIDENT, CHAIRMAN, CEO · Transaction Code A
Traded Aug 16, 2026 · Disclosed Aug 18, 2026
Source: SEC Form 4 · 0001493152-26-039048 · filed 2026-08-18 · View filing →